Breast Cancer Coverage from Every Angle

Youssef Zeidan, MD, PhD, on Boosting Radiation for HER2-Positive Breast Cancer: Why It May Not Be Necessary

Posted: Wednesday, October 28, 2020

Youssef Zeidan, MD, PhD, of the American University of Beirut Medical Center, talks about his study on whether clinicians can safely forgo intensifying radiation as part of the standard regimen for patients with HER2-positive breast cancer. He also offers clinical pearls on helping patients manage treatment side effects.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.